GT-02287
GANX-001-V102
Phase 1 small_molecule active
Quick answer
GT-02287 for Parkinson Disease is a Phase 1 program (small_molecule) at Gain Therapeutics with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Gain Therapeutics
- Indication
- Parkinson Disease
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- active